Research & Innovation

Opt-IVF was created after 10 years of theoretical research and clinical trials. Dr. Diwekar used a hybrid approach combining first-principle-based and data-driven techniques to develop a model that describes follicular maturation in humans using theories derived from particulate growth in nature.

This groundbreaking work applies optimal control theory to a biological system, resulting in a tool that provides personalized recommendations and significantly improves patient outcomes.

Request demo Learn more

Founder, Chief Research Officer

Meet our awesome research leader who make all of this possible. From a dream to pioneering research, Dr. Diwekar is deeply committed to improving IVF outcomes and pregnancy success rates.

Dr. Urmila Diwekar

Dr. Urmila Diwekar, MTech, PhD, is a distinguished chemical and biomedical engineer, and scientist with a remarkable academic and professional background. Her work spans across multiple fields including reproductive medicine, biomedical applications, and advanced optimization techniques for IVF treatments.

As the founder of Opt-IVF LLC, she has been instrumental in developing cutting-edge medical solutions to complex problems. Her work with Opt-IVF represents a significant breakthrough in the field of reproductive medicine, applying principles of engineering and optimization to improve IVF outcomes.

Get in touch with us Learn more

Key Research Innovations

  • Application of stochastic optimization to follicular growth
  • Development of personalized mathematical models
  • Integration of engineering principles with reproductive medicine
  • Clinical validation through multiple randomized trials

Journal Publications

The clinical decision support tool optimizes superovulation by reducing FSH dosage and monitoring needs while significantly increasing the number of high-quality embryos and clinical pregnancy rates compared with standard practice.

IVF Stimulation - personalized, optimized, and simplified using an advanced decision-support tool: A randomized trial

Journal of IVF-Worldwide

Read Journal Publication
Opt-IVF optimizes controlled ovarian stimulation by reducing gonadotropin dosage and monitoring requirements while increasing oocyte yield, blastocyst quality, and pregnancy rates compared with standard clinical practice.

A Multi-center Clinical Trial for Opt-IVF

Reproduction & Fertility

Read Journal Publication
Opt-IVF optimizes controlled ovarian stimulation by reducing FSH dosage and monitoring needs while increasing M2 oocytes, high-quality blastocysts, and pregnancy rates across all patient types and IVF protocols.

A multicenter randomized clinical trial with a novel decision support tool to improve IVF success

Reproduction & Fertility

Read Journal Publication
Opt-IVF streamlines superovulation by reducing FSH dosage and eliminating post-day-5 ultrasounds while significantly increasing the number of high-quality embryos across normal, poor responder, and PCOS patients.

A Non-Randomized Clinical Trial of a Decision Support Tool to Optimize Superovulation Cycles in Individual Patient

Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biol

Read Journal Publication
Opt-IVF reduces gonadotropin dosage and increases total and high-quality embryos, improving clinical pregnancy rates particularly for older patients and poor responders.

ENHANCED CLINICAL PREGNANCY RATES UTILIZING A CLINICAL DECISION SUPPORT TOOL: A RETROSPECTIVE COHORT STUDY

Indian Obstetrics and Gynaecology Journal

Read Journal Publication

Experience the Innovation

Join the growing number of medical professionals using Dr. Diwekar's revolutionary technology to improve IVF outcomes and patient experiences.

Research-Based

Backed by 10 years of rigorous theoretical research

Clinically Proven

Validated through multiple peer-reviewed studies

Award Winning

Recognized for innovation and clinical impact